|
Originally published In Press as doi:10.1074/jbc.M209125200 on October 29, 2002
J. Biol. Chem., Vol. 278, Issue 1, 407-414, January 3, 2003
Antitumor Effects of Photodynamic Therapy Are Potentiated by
2-Methoxyestradiol
A SUPEROXIDE DISMUTASE INHIBITOR*
Jakub
Go b §,
Dominika
Nowis ,
Micha
Skrzycki¶,
Hanna
Czeczot¶,
Anna
Bara czyk-Ku ma¶,
Grzegorz M.
Wilczy ski ,
Marcin
Makowski ,
Pawe
Mróz ,
Katarzyna
Kozar ,
Rafa
Kami ski ,
Ahmad
Jalili ,
Maciej
Kope ,
Tomasz
Grzela** , and
Marek
Jakóbisiak
From the Departments of Immunology,
¶ Biochemistry, Pathology, and ** Histology and
Embryology, Center of Biostructure Research, and the
 Department of General and Vascular Surgery
and Transplantation, The Medical University of Warsaw, 02-004 Warsaw, Poland
Photodynamic therapy (PDT), a promising
therapeutic modality for the management of solid tumors, is a two-phase
treatment consisting of a photosensitizer and visible light. Increasing evidence indicates that tumor cells in regions exposed to sublethal doses of PDT can respond by rescue responses that lead to insufficient cell death. We decided to examine the role of superoxide dismutases (SODs) in the effectiveness of PDT and to investigate whether 2-methoxyestradiol (2-MeOE2), an inhibitor of SODs,
is capable of potentiating the antitumor effects of this treatment
regimen. In the initial experiment we observed that PDT induced the
expression of MnSOD but not Cu,Zn-SOD in cancer cells. Pretreatment of
cancer cells with a cell-permeable SOD mimetic,
Mn(II)-tetrakis(4-benzoic acid)porphyrin chloride, and transient
transfection with the MnSOD gene resulted in a decreased effectiveness
of PDT. Inhibition of SOD activity in tumor cells by preincubation with
2-MeOE2 produced synergistic antitumor effects when
combined with PDT in 3 murine and 5 human tumor cell lines. The
combination treatment was also effective in vivo producing
retardation of the tumor growth and prolongation of the survival of
tumor-bearing mice. We conclude that inhibition of MnSOD activity by
2-MeOE2 is an effective treatment modality capable of
potentiating the antitumor effectiveness of PDT.
*
This work was supported by Grant 1M19/M2/2000 from the
Medical University of Warsaw, Poland, Grant 4 P05A 025 18 from the State Committee for Scientific Research (to K. B. N.), and a
grant from the Foundation for Polish Science (to F. N. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Immunology,
Center of Biostructure Research, The Medical University of Warsaw, Cha ubi skiego 5, 02-004 Warsaw, Poland.
Tel./Fax: 48-22-622-6306; E-mail: jgolab@ib.amwaw.edu.pl.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Aiken, J. S. Bickford, M. S. Kilberg, and H. S. Nick
Metabolic Regulation of Manganese Superoxide Dismutase Expression via Essential Amino Acid Deprivation
J. Biol. Chem.,
April 18, 2008;
283(16):
10252 - 10263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Ricci and W.-X. Zong
Chemotherapeutic approaches for targeting cell death pathways.
Oncologist,
April 1, 2006;
11(4):
342 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-X. Zong and C. B. Thompson
Necrotic death as a cell fate.
Genes & Dev.,
January 1, 2006;
20(1):
1 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Wild, R. C. Krieg, J. Seidl, R. Stoehr, K. Reher, C. Hofmann, J. Louhelainen, A. Rosenthal, A. Hartmann, C. Pilarsky, et al.
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro
Mol. Cancer Ther.,
April 1, 2005;
4(4):
516 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Sutherland, M. Schuliga, T. Harris, B. L. Eckhardt, R. L. Anderson, L. Quan, and A. G. Stewart
2-Methoxyestradiol Is an Estrogen Receptor Agonist That Supports Tumor Growth in Murine Xenograft Models of Breast Cancer
Clin. Cancer Res.,
March 1, 2005;
11(5):
1722 - 1732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. L. Belladonna, M. C. Fioretti, D. V. Serreze, U. Grohmann, and P. Puccetti
CTLA-4-Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
J. Exp. Med.,
October 18, 2004;
200(8):
1051 - 1062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Achanta and P. Huang
Role of p53 in Sensing Oxidative DNA Damage in Response to Reactive Oxygen Species-Generating Agents
Cancer Res.,
September 1, 2004;
64(17):
6233 - 6239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, et al.
Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells
Clin. Cancer Res.,
July 1, 2004;
10(13):
4498 - 4508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Makowski, T. Grzela, J. Niderla, M. Lazarczyk, P. Mroz, M. Kopee, M. Legat, K. Strusinska, K. Koziak, D. Nowis, et al.
Inhibition of Cyclooxygenase-2 Indirectly Potentiates Antitumor Effects of Photodynamic Therapy in Mice
Clin. Cancer Res.,
November 1, 2003;
9(14):
5417 - 5422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pelicano, L. Feng, Y. Zhou, J. S. Carew, E. O. Hileman, W. Plunkett, M. J. Keating, and P. Huang
Inhibition of Mitochondrial Respiration: A NOVEL STRATEGY TO ENHANCE DRUG-INDUCED APOPTOSIS IN HUMAN LEUKEMIA CELLS BY A REACTIVE OXYGEN SPECIES-MEDIATED MECHANISM
J. Biol. Chem.,
September 26, 2003;
278(39):
37832 - 37839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kozar, R. Kaminski, T. Switaj, T. Oldak, E. Machaj, P. J. Wysocki, A. Mackiewicz, W. Lasek, M. Jakobisiak, and J. Golab
Interleukin 12-based Immunotherapy Improves the Antitumor Effectiveness of a Low-Dose 5-Aza-2'-Deoxycitidine Treatment in L1210 Leukemia and B16F10 Melanoma Models in Mice
Clin. Cancer Res.,
August 1, 2003;
9(8):
3124 - 3133.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|